Filing Flows › Comparisons › RLAY vs BEAM
Relay Therapeutics vs Beam Therapeutics: RLAY and BEAM compared
Relay Therapeutics is the larger company: $350K of revenue in its latest quarter (Q2 2026) against $307K for Beam Therapeutics (Q3 2026). Relay Therapeutics is growing faster (-48% against -97% a year earlier).
Where the money goes: RLAY and BEAM
Relay Therapeutics (RLAY) · Q2 2026
Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart follows the revenue to costs, profit and cash.
Beam Therapeutics (BEAM) · Q3 2026
Beam Therapeutics, Q3 2026: revenue $307K (-97% year over year), net loss $134M, operating cash flow −$111M. The chart follows the revenue to costs, profit and cash.
| Relay Therapeutics (RLAY) | Beam Therapeutics (BEAM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $350K | $307K |
| Revenue growth, Y/Y | -48% | -97% |
| Operating margin | n/m | n/m |
| Net earnings | −$83.7M | −$134M |
| Operating cash flow | −$54.1M | −$111M |
Questions
Which is bigger, Relay Therapeutics or Beam Therapeutics?
Relay Therapeutics is the larger company: $350K of revenue in its latest quarter (Q2 2026) against $307K for Beam Therapeutics (Q3 2026).
Is Relay Therapeutics or Beam Therapeutics growing faster?
Relay Therapeutics is growing faster (-48% against -97% a year earlier).
More: Relay Therapeutics earnings · how Relay Therapeutics makes money · Beam Therapeutics earnings · how Beam Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.